These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7551062)

  • 21. Molecular characterization of Salmonella enterica Serotype Typhi isolates by pulsed-field gel electrophoresis in Hong Kong, 2000-2004.
    Kam KM; Luey KY; Chiu AW; Law CP; Leung SF
    Foodborne Pathog Dis; 2007; 4(1):41-9. PubMed ID: 17378707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a Live Attenuated Bivalent Oral Vaccine Against Shigella sonnei Shigellosis and Typhoid Fever.
    Wu Y; Chakravarty S; Li M; Wai TT; Hoffman SL; Sim BK
    J Infect Dis; 2017 Jan; 215(2):259-268. PubMed ID: 27803169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salmonella-based vaccines.
    Hackett J
    Vaccine; 1990 Feb; 8(1):5-11. PubMed ID: 2180232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of CD8(+) effector T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine.
    Salerno-Goncalves R; Pasetti MF; Sztein MB
    J Immunol; 2002 Aug; 169(4):2196-203. PubMed ID: 12165550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotypic characterization of Salmonella typhi by amplified fragment length polymorphism fingerprinting provides increased discrimination as compared to pulsed-field gel electrophoresis and ribotyping.
    Nair S; Schreiber E; Thong KL; Pang T; Altwegg M
    J Microbiol Methods; 2000 Jun; 41(1):35-43. PubMed ID: 10856775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Manipulation of
    Salerno-Gonçalves R; Galen JE; Levine MM; Fasano A; Sztein MB
    Front Immunol; 2018; 9():2543. PubMed ID: 30443257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers.
    Hohmann EL; Oletta CA; Killeen KP; Miller SI
    J Infect Dis; 1996 Jun; 173(6):1408-14. PubMed ID: 8648213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and characterization of a Salmonella enterica serotype Typhi variant and its clinical and public health implications.
    Woo PC; Fung AM; Wong SS; Tsoi HW; Yuen KY
    J Clin Microbiol; 2001 Mar; 39(3):1190-4. PubMed ID: 11230457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and field trials with attenuated Salmonella typhi as live oral vaccines and as "carrier" vaccines.
    Levine MM; Hone D; Tacket C; Ferreccio C; Cryz S
    Res Microbiol; 1990; 141(7-8):807-16. PubMed ID: 2101470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers.
    Metzger WG; Mansouri E; Kronawitter M; Diescher S; Soerensen M; Hurwitz R; Bumann D; Aebischer T; Von Specht BU; Meyer TF
    Vaccine; 2004 Jun; 22(17-18):2273-7. PubMed ID: 15149786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salmonella typhi vaccine strain in vitro; low infectivity in human cell line U937.
    Dragunsky EM; Wooden CR; Vargo SA; Levenbook IS
    J Biol Stand; 1989 Oct; 17(4):353-60. PubMed ID: 2613709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A method to generate recombinant Salmonella typhi Ty21a strains expressing multiple heterologous genes using an improved recombineering strategy.
    Yu B; Yang M; Wong HY; Watt RM; Song E; Zheng BJ; Yuen KY; Huang JD
    Appl Microbiol Biotechnol; 2011 Jul; 91(1):177-88. PubMed ID: 21611798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The molecular epidemiology of Salmonella Typhi across Indonesia reveals bacterial migration.
    Moehario LH
    J Infect Dev Ctries; 2009 Sep; 3(8):579-84. PubMed ID: 19801799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a.
    Darton TC; Jones C; Blohmke CJ; Waddington CS; Zhou L; Peters A; Haworth K; Sie R; Green CA; Jeppesen CA; Moore M; Thompson BA; John T; Kingsley RA; Yu LM; Voysey M; Hindle Z; Lockhart S; Sztein MB; Dougan G; Angus B; Levine MM; Pollard AJ
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004926. PubMed ID: 27533046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brucella melitensis 16M: characterisation of the galE gene and mouse immunisation studies with a galE deficient mutant.
    Petrovska L; Hewinson RG; Dougan G; Maskell DJ; Woodward MJ
    Vet Microbiol; 1999 Feb; 65(1):21-36. PubMed ID: 10068125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of random amplified polymorphic DNA analysis to differentiate strains of Salmonella typhi and other Salmonella species.
    Shangkuan YH; Lin HC
    J Appl Microbiol; 1998 Oct; 85(4):693-702. PubMed ID: 9812381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction of a genetically defined Salmonella typhi Ty2 aroA, aroC mutant for the engineering of a candidate oral typhoid-tetanus vaccine.
    Chatfield SN; Fairweather N; Charles I; Pickard D; Levine M; Hone D; Posada M; Strugnell RA; Dougan G
    Vaccine; 1992; 10(1):53-60. PubMed ID: 1311488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of pulsed field gel electrophoresis as an epidemiological tool for analysis of sporadic associated strains of Salmonella typhi isolated in Taiwan.
    Tsen HY; Lin JS; Hu HH; Liu PR; Wang TK
    J Appl Microbiol; 1999 May; 86(5):761-8. PubMed ID: 10347870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome fingerprinting of Salmonella typhi by pulsed-field gel electrophoresis for subtyping common phage types.
    Nair S; Poh CL; Lim YS; Tay L; Goh KT
    Epidemiol Infect; 1994 Dec; 113(3):391-402. PubMed ID: 7995349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A galE via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in humans.
    Hone DM; Attridge SR; Forrest B; Morona R; Daniels D; LaBrooy JT; Bartholomeusz RC; Shearman DJ; Hackett J
    Infect Immun; 1988 May; 56(5):1326-33. PubMed ID: 3356467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.